The U.S. FDA is coordinating with Indian drug manufacturers to address the domestic shortage of the cancer drug Ifosfamide, ensuring continuous access to critical treatments.
Williams··2 min read
The medical community is pursuing a 'functional cure' for Hepatitis B, with new siRNA therapies like imdusiran showing potential in clinical trials. While results are positive, experts remain cautious, calling for more data to confirm long-term efficacy.
Williams··2 min read
Silicon Valley's interest in performance-enhancing peptides is growing, often linked to the controversial 'Enhanced Games.' While market fervor is high, the lack of clinical safety validation and significant ethical concerns pose major challenges.
Williams··2 min read
The 'Enhanced Games' allows performance-enhancing drugs for athletes, igniting a fierce clash between Silicon Valley biohacking culture and traditional international sporting ethics.
Williams··2 min read
CAR T-cell therapy, traditionally used for cancer, is being successfully adapted to treat complex autoimmune diseases by 'resetting' the immune system, showing great promise in recent clinical studies.
Williams··2 min read
CAR T-cell therapy is expanding beyond cancer treatment, showing significant potential as a revolutionary approach to autoimmune diseases. Recent studies demonstrate its ability to 'reset' the immune system by selectively eliminating disease-driving cells. This breakthrough marks a transition for cell therapy from a single-use cancer tool to a flexible, programmable platform for immune remodeling.
Williams··2 min read
At WIRED Health, expert Ara Darzi highlighted AI's potential to revolutionize the diagnosis and treatment of drug-resistant infections, while noting that a lack of economic incentives for drug discovery remains a major barrier.
Williams··2 min read
Isomorphic Labs is advancing AI-designed drugs into human clinical trials, confirming the technology's potential to significantly accelerate and improve pharmaceutical development.
Williams··1 min read